• Ph.D. with 10+ years of holistic academic & industry experience in Research and Process/Analytics Development with current focus on allogeneic and autologous CAR-T Cell Therapies, Gene-Editing, and Cell Engineering supporting critical need early phase patient therapies. • Dedicated Team Leader for Gene-Editing Process/ Analytical (cell-based assays) Development and Lifecycle and Process Improvement with CMC development teams for IND and BLA enabling platforms.- Cell and Gene Engineering • Experienced in cell culture (traditional and closed system automation), cell line development (CHO, HEK293, NIH3T3, U2SO), lentivirus engineering, lentivirus transduction, viral/ nonviral gene editing, electroporation, flow cytometry, cell sorting, IF, PCR, and cloning • Investigated mRNA transcription dynamics through spatially resolved genomic approaches (Cas9/ FISH/ MS2) - Cell-based Assay, Large Molecule Characterization, and Programming • Execution of Incucyte and 16+ color BD FACSymphony A5 flow cytometry • Created custom-build FCS, confocal, and 2P microscopies for bioimaging • Studied protein interactions using DLS, spectroscopy, SPR, microscopy, optical tweezers, and electrophoresis • Analyses and automatic measurements via FlowJo, FCS, MATLAB, ImageJ, JMP, and LabView My background in cell engineering and biophysics includes 1) cell and genomic engineering in cell therapies; 2) biophysics in protein interaction; 3) synthetic proteins in transcriptomics; 4) the lipid-nanoparticle (LNP)/ colloidal interactions in the optical and electrical field; 5) biomaterials in regenerative medicine.